PE20010826A1 - Soluciones que contienen epinastina - Google Patents

Soluciones que contienen epinastina

Info

Publication number
PE20010826A1
PE20010826A1 PE2000001201A PE0012012000A PE20010826A1 PE 20010826 A1 PE20010826 A1 PE 20010826A1 PE 2000001201 A PE2000001201 A PE 2000001201A PE 0012012000 A PE0012012000 A PE 0012012000A PE 20010826 A1 PE20010826 A1 PE 20010826A1
Authority
PE
Peru
Prior art keywords
solutions containing
solution
containing epinastine
enanthymers
conjunctivity
Prior art date
Application number
PE2000001201A
Other languages
English (en)
Inventor
Volker Trach
Gerold Duschler
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010826(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20010826A1 publication Critical patent/PE20010826A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

SE REFIERE A SOLUCIONES ACUOSAS TOPICAS QUE CONTIENE HIDROCLORURO DE EPINASTINA (3-AMINO-9,13b-DIHIDRO-1H-DIBENZO-[c,f]-IMIDAZOL-[1,5-a]AZEPINA, EN FORMA DE RACEMATO, ENANTIOMEROS, SALES DE ADICION DE ACIDOS; EN UNA CONCENTRACION DE 0,005 mg/ml. A 0,5 mg/ml. DE SOLUCION; CARACTERIZADA PORQUE SE AJUSTA A UN VALOR DE pH DE 6,5 A 7,2 CON UN TAMPON; ADEMAS CONTIENE UN AGENTE DE CONSERVACION. LA SOLUCION PUEDE SER UTIL PARA LA INHIBICION DE LA AFLUENCIA DE NEUTROFILOS Y EOSINOFILOS EN EL TEJIDO DE LA CONJUNTIVA DEL OJO O EN EL DE LA MUCOSA NASAL
PE2000001201A 1999-11-12 2000-11-10 Soluciones que contienen epinastina PE20010826A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen

Publications (1)

Publication Number Publication Date
PE20010826A1 true PE20010826A1 (es) 2001-08-20

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001201A PE20010826A1 (es) 1999-11-12 2000-11-10 Soluciones que contienen epinastina

Country Status (40)

Country Link
US (6) US20030050303A1 (es)
EP (1) EP1231920B1 (es)
JP (1) JP2003514021A (es)
KR (1) KR100758842B1 (es)
CN (1) CN1292752C (es)
AR (1) AR026424A1 (es)
AT (1) ATE353218T1 (es)
AU (2) AU784017B2 (es)
BG (1) BG65775B1 (es)
BR (1) BR0015477A (es)
CA (1) CA2391076C (es)
CO (1) CO5251448A1 (es)
CY (1) CY1106375T1 (es)
CZ (1) CZ302483B6 (es)
DE (2) DE19954516A1 (es)
DK (1) DK1231920T3 (es)
EA (1) EA006937B1 (es)
EE (1) EE05395B1 (es)
ES (1) ES2281359T3 (es)
HK (1) HK1052303B (es)
HR (1) HRP20020404B1 (es)
HU (1) HU229502B1 (es)
IL (2) IL149501A0 (es)
ME (1) MEP36708A (es)
MX (1) MXPA02004556A (es)
MY (1) MY130441A (es)
NO (1) NO329417B1 (es)
NZ (1) NZ519425A (es)
PE (1) PE20010826A1 (es)
PL (1) PL198879B1 (es)
PT (1) PT1231920E (es)
RS (1) RS50173B (es)
SA (1) SA01210658B1 (es)
SI (1) SI1231920T1 (es)
SK (1) SK287343B6 (es)
TR (1) TR200201270T2 (es)
TW (1) TWI225401B (es)
UA (1) UA74563C2 (es)
WO (1) WO2001035962A1 (es)
ZA (1) ZA200203683B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
NZ708821A (en) * 2012-12-19 2020-03-27 Novartis Ag Lfa-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
WO2018203424A1 (ja) * 2017-05-01 2018-11-08 参天製薬株式会社 点眼剤
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8632A (en) * 1852-01-06 George hess
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US215396A (en) * 1879-05-13 Improvement in loom-temples
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US228359A (en) * 1880-06-01 jones
US181478A (en) * 1876-08-22 Improvement in water-wheels
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
ES2183001T3 (es) * 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
KR20000035846A (ko) * 1996-08-30 2000-06-26 교토 야쿠힝 고교 가부시키가이샤 앨러지성 피부염 치료제
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
AU772406B2 (en) * 1999-11-18 2004-04-29 Alcon Inc. Use of H1 antagonist and a safe steroid to treat eye conditions
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
YU33602A (sh) 2005-03-15
SI1231920T1 (sl) 2007-06-30
JP2003514021A (ja) 2003-04-15
CY1106375T1 (el) 2011-10-12
PL364028A1 (en) 2004-11-29
NO329417B1 (no) 2010-10-18
US20070197503A1 (en) 2007-08-23
KR100758842B1 (ko) 2007-09-19
ZA200203683B (en) 2003-09-03
HU229502B1 (en) 2014-01-28
BR0015477A (pt) 2002-06-25
RS50173B (sr) 2009-05-06
EE05395B1 (et) 2011-04-15
ES2281359T3 (es) 2007-10-01
US20090239842A1 (en) 2009-09-24
MXPA02004556A (es) 2004-09-10
PT1231920E (pt) 2007-03-30
HK1052303A1 (en) 2003-09-11
EA006937B1 (ru) 2006-06-30
SK287343B6 (sk) 2010-07-07
UA74563C2 (uk) 2006-01-16
CA2391076C (en) 2008-06-17
AU1138101A (en) 2001-05-30
PL198879B1 (pl) 2008-07-31
IL149501A0 (en) 2002-11-10
NO20022201L (no) 2002-05-08
CO5251448A1 (es) 2003-02-28
US20030050303A1 (en) 2003-03-13
US7429602B2 (en) 2008-09-30
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
IL149501A (en) 2012-04-30
DE19954516A1 (de) 2001-05-17
HK1052303B (zh) 2007-04-13
BG106681A (en) 2002-12-29
KR20020050273A (ko) 2002-06-26
EE200200246A (et) 2003-06-16
DE50014041D1 (de) 2007-03-22
MEP36708A (en) 2011-02-10
AU784017B2 (en) 2006-01-12
MY130441A (en) 2007-06-29
DK1231920T3 (da) 2007-04-10
NZ519425A (en) 2004-04-30
BG65775B1 (bg) 2009-11-30
HUP0203773A3 (en) 2005-01-28
EP1231920A1 (de) 2002-08-21
EP1231920B1 (de) 2007-02-07
CZ20021956A3 (cs) 2002-08-14
HRP20020404B1 (en) 2007-08-31
US20070185082A1 (en) 2007-08-09
WO2001035962A1 (de) 2001-05-25
ATE353218T1 (de) 2007-02-15
SA01210658B1 (ar) 2006-11-05
CZ302483B6 (cs) 2011-06-08
US20050288274A1 (en) 2005-12-29
US20080009476A1 (en) 2008-01-10
CA2391076A1 (en) 2001-05-25
CN1390129A (zh) 2003-01-08
AR026424A1 (es) 2003-02-12
EA200200492A1 (ru) 2002-10-31
CN1292752C (zh) 2007-01-03
AU2006201541A1 (en) 2006-05-11
SK8302002A3 (en) 2002-09-10
TR200201270T2 (tr) 2002-12-23

Similar Documents

Publication Publication Date Title
PE20010826A1 (es) Soluciones que contienen epinastina
CO5190689A1 (es) Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales
ES2152412T3 (es) Preparacion farmaceuticamente estable de oxaliplatino.
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
BR0101332A (pt) Formulação oftálmica tópica na forma de uma solução aquosa, e, uso de uma ciclosporina em associação com ácido hialurÈnico ou um de seus sais e com polisorbato 80
PT814782E (pt) Composicao farmaceutica estabilizada com um agente basico
NZ508037A (en) A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
PE20010400A1 (es) Formulacion de sal comun y moxifloxacina
PT1255557E (pt) Preparacao farmaceutica estavel de aplicacao nasal oral ou sub-lingual contendo desmopressina
ES2174109T3 (es) Composicion antibacteriana para administracion oral.
CO5180582A1 (es) Soluciones farmaceuticas de levosimendan
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
CO5640085A2 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
JP2004537546A5 (es)
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
PT1150660E (pt) Formulacao farmaceutica efervescente contendo metamizole
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
ATE408413T1 (de) Pralmorelin-haltige nasentropfen-präparate
ES2181415T3 (es) Composicion acuosa ionica que contiene levomentol.
SE9700617D0 (sv) New composition
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
TR199902573A2 (xx) Keçe yastıklı antiseptik nasır yakısı.
ECSP910716A (es) Procedimiento para preparar un producto de celulosa oxidada, neutralizada y metodo de uso del mismo

Legal Events

Date Code Title Description
FC Refusal